{"ticker": "GRPH", "overview": {"cik": "1815776", "ticker": "LENZ", "name": "LENZ Therapeutics, Inc.", "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "sic": "2836", "announcements": [{"form": "8-K", "date": "2026-07-02", "title": "Material event", "accession": "0001815776-26-000046", "price_sensitive": true}, {"form": "SCHEDULE 13G", "date": "2026-06-26", "title": "Form SCHEDULE 13G", "accession": "0001104659-26-078313", "price_sensitive": false}, {"form": "4", "date": "2026-06-15", "title": "Insider transaction", "accession": "0001231919-26-000640", "price_sensitive": false}, {"form": "4", "date": "2026-06-15", "title": "FORM 4", "accession": "0001796789-26-000004", "price_sensitive": false}, {"form": "4", "date": "2026-06-15", "title": "FORM 4", "accession": "0001340881-26-000001", "price_sensitive": false}, {"form": "4", "date": "2026-06-15", "title": "FORM 4", "accession": "0001200889-26-000001", "price_sensitive": false}, {"form": "4", "date": "2026-06-15", "title": "FORM 4", "accession": "0001297491-26-000001", "price_sensitive": false}, {"form": "4", "date": "2026-06-15", "title": "FORM 4", "accession": "0001825009-26-000001", "price_sensitive": false}, {"form": "4", "date": "2026-06-15", "title": "FORM 4", "accession": "0001816523-26-000005", "price_sensitive": false}, {"form": "8-K", "date": "2026-06-12", "title": "Material event", "accession": "0001815776-26-000041", "price_sensitive": true}, {"form": "10-Q", "date": "2026-05-11", "title": "Quarterly report", "accession": "0001815776-26-000037", "price_sensitive": true}, {"form": "8-K", "date": "2026-05-11", "title": "Material event", "accession": "0001815776-26-000035", "price_sensitive": true}, {"form": "ARS", "date": "2026-04-28", "title": "Form ARS", "accession": "0001815776-26-000029", "price_sensitive": false}, {"form": "DEFA14A", "date": "2026-04-28", "title": "Form DEFA14A", "accession": "0001815776-26-000028", "price_sensitive": false}, {"form": "DEF 14A", "date": "2026-04-28", "title": "Proxy statement", "accession": "0001815776-26-000026", "price_sensitive": false}, {"form": "SCHEDULE 13G", "date": "2026-04-27", "title": "Form SCHEDULE 13G", "accession": "0002012383-26-001701", "price_sensitive": false}, {"form": "SCHEDULE 13G", "date": "2026-04-08", "title": "Form SCHEDULE 13G", "accession": "0001642575-26-000004", "price_sensitive": false}, {"form": "4", "date": "2026-03-30", "title": "FORM 4", "accession": "0001796789-26-000003", "price_sensitive": false}, {"form": "4", "date": "2026-03-30", "title": "FORM 4", "accession": "0001713795-26-000004", "price_sensitive": false}, {"form": "4", "date": "2026-03-30", "title": "FORM 4", "accession": "0001706176-26-000004", "price_sensitive": false}, {"form": "S-8", "date": "2026-03-24", "title": "Employee share plan", "accession": "0001815776-26-000013", "price_sensitive": false}, {"form": "10-K", "date": "2026-03-24", "title": "Annual report", "accession": "0001815776-26-000011", "price_sensitive": true}, {"form": "8-K", "date": "2026-03-24", "title": "Material event", "accession": "0001815776-26-000008", "price_sensitive": true}, {"form": "SCHEDULE 13G/A", "date": "2026-02-17", "title": "Form SCHEDULE 13G/A", "accession": "0001104659-26-016363", "price_sensitive": false}, {"form": "SCHEDULE 13G/A", "date": "2026-02-05", "title": "Form SCHEDULE 13G/A", "accession": "0000315066-26-000453", "price_sensitive": false}]}, "description": "GRPH trades as GRPH. Privy Trades holds 44 insider filings for the company, from June 2021 to April 2022. Across those, 5 insiders disclosed 12 open-market purchases totalling $23.37M. The most recent filing on record is dated 28 July 2023.", "exchange": null, "stats": {"buy_n": 12, "buy_sum": 23370162.93, "sell_n": 0, "sell_sum": 0, "net": 23370162.93, "insiders": 5, "first_date": "2021-06-29", "last_date": "2022-04-12"}, "metrics": {"ticker": "GRPH", "has_prices": false}, "trades": [{"id": "0001209191-23-044075", "src": "INSIDERS", "ticker": "GRPH", "cik": "1815776", "company": "LENZ Therapeutics, Inc.", "company_raw": "Graphite Bio, Inc.", "who": "Kimberlee C. Drapkin", "who_key": "Drapkin Kimberlee C", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on GRPH \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1815776/000120919123044075/0001209191-23-044075-index.htm", "trade_date": "2023-07-28", "timestamp": "2023-07-28", "mins": 1718870}, {"id": "0001209191-23-043123", "src": "INSIDERS", "ticker": "GRPH", "cik": "1815776", "company": "LENZ Therapeutics, Inc.", "company_raw": "Graphite Bio, Inc.", "who": "Kristen Hege", "who_key": "Hege Kristen", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on GRPH \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1815776/000120919123043123/0001209191-23-043123-index.htm", "trade_date": "2023-07-19", "timestamp": "2023-07-19", "mins": 1731830}, {"id": "0001209191-23-043125", "src": "INSIDERS", "ticker": "GRPH", "cik": "1815776", "company": "LENZ Therapeutics, Inc.", "company_raw": "Graphite Bio, Inc.", "who": "Smital Shah", "who_key": "Shah Smital", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on GRPH \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1815776/000120919123043125/0001209191-23-043125-index.htm", "trade_date": "2023-07-19", "timestamp": "2023-07-19", "mins": 1731830}, {"id": "0001209191-23-043129", "src": "INSIDERS", "ticker": "GRPH", "cik": "1815776", "company": "LENZ Therapeutics, Inc.", "company_raw": "Graphite Bio, Inc.", "who": "Abraham Bassan", "who_key": "Bassan Abraham", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on GRPH \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1815776/000120919123043129/0001209191-23-043129-index.htm", "trade_date": "2023-07-19", "timestamp": "2023-07-19", "mins": 1731830}, {"id": "0001209191-23-043131", "src": "INSIDERS", "ticker": "GRPH", "cik": "1815776", "company": "LENZ Therapeutics, Inc.", "company_raw": "Graphite Bio, Inc.", "who": "Rizzuto Carlo", "who_key": "Carlo Rizzuto", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on GRPH \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1815776/000120919123043131/0001209191-23-043131-index.htm", "trade_date": "2023-07-19", "timestamp": "2023-07-19", "mins": 1731830}, {"id": "0001209191-23-043134", "src": "INSIDERS", "ticker": "GRPH", "cik": "1815776", "company": "LENZ Therapeutics, Inc.", "company_raw": "Graphite Bio, Inc.", "who": "Davis Jerel", "who_key": "Jerel Davis", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on GRPH \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1815776/000120919123043134/0001209191-23-043134-index.htm", "trade_date": "2023-07-19", "timestamp": "2023-07-19", "mins": 1731830}, {"id": "0001209191-23-043137", "src": "INSIDERS", "ticker": "GRPH", "cik": "1815776", "company": "LENZ Therapeutics, Inc.", "company_raw": "Graphite Bio, Inc.", "who": "Joseph Jimenez", "who_key": "JIMENEZ JOSEPH", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on GRPH \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1815776/000120919123043137/0001209191-23-043137-index.htm", "trade_date": "2023-07-19", "timestamp": "2023-07-19", "mins": 1731830}, {"id": "0001209191-23-043140", "src": "INSIDERS", "ticker": "GRPH", "cik": "1815776", "company": "LENZ Therapeutics, Inc.", "company_raw": "Graphite Bio, Inc.", "who": "Perry A. Karsen", "who_key": "KARSEN PERRY A", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on GRPH \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1815776/000120919123043140/0001209191-23-043140-index.htm", "trade_date": "2023-07-19", "timestamp": "2023-07-19", "mins": 1731830}, {"id": "0001209191-23-043142", "src": "INSIDERS", "ticker": "GRPH", "cik": "1815776", "company": "LENZ Therapeutics, Inc.", "company_raw": "Graphite Bio, Inc.", "who": "Matthew Porteus", "who_key": "Porteus Matthew", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on GRPH \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1815776/000120919123043142/0001209191-23-043142-index.htm", "trade_date": "2023-07-19", "timestamp": "2023-07-19", "mins": 1731830}, {"id": "0001209191-23-043145", "src": "INSIDERS", "ticker": "GRPH", "cik": "1815776", "company": "LENZ Therapeutics, Inc.", "company_raw": "Graphite Bio, Inc.", "who": "Joanne L. Viney", "who_key": "Viney Joanne L.", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on GRPH \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1815776/000120919123043145/0001209191-23-043145-index.htm", "trade_date": "2023-07-19", "timestamp": "2023-07-19", "mins": 1731830}, {"id": "0001209191-23-012259", "src": "INSIDERS", "ticker": "GRPH", "cik": "1815776", "company": "LENZ Therapeutics, Inc.", "company_raw": "Graphite Bio, Inc.", "who": "Joshua Lehrer-Graiwer", "who_key": "Lehrer-Graiwer Joshua", "role": "PRESIDENT AND CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "CEO files routine paperwork on GRPH \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1815776/000120919123012259/0001209191-23-012259-index.htm", "trade_date": "2023-02-21", "timestamp": "2023-02-21", "mins": 1944950}, {"id": "0001209191-23-012264", "src": "INSIDERS", "ticker": "GRPH", "cik": "1815776", "company": "LENZ Therapeutics, Inc.", "company_raw": "Graphite Bio, Inc.", "who": "Alethia Young", "who_key": "Young Alethia", "role": "Chief Financial Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "CFO files routine paperwork on GRPH \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1815776/000120919123012264/0001209191-23-012264-index.htm", "trade_date": "2023-02-21", "timestamp": "2023-02-21", "mins": 1944950}, {"id": "0001209191-22-038725", "src": "INSIDERS", "ticker": "GRPH", "cik": "1815776", "company": "LENZ Therapeutics, Inc.", "company_raw": "Graphite Bio, Inc.", "who": "Kristen Hege", "who_key": "Hege Kristen", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on GRPH \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1815776/000120919122038725/0001209191-22-038725-index.htm", "trade_date": "2022-06-21", "timestamp": "2022-06-21", "mins": 2297750}, {"id": "0001209191-22-038727", "src": "INSIDERS", "ticker": "GRPH", "cik": "1815776", "company": "LENZ Therapeutics, Inc.", "company_raw": "Graphite Bio, Inc.", "who": "Smital Shah", "who_key": "Shah Smital", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on GRPH \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1815776/000120919122038727/0001209191-22-038727-index.htm", "trade_date": "2022-06-21", "timestamp": "2022-06-21", "mins": 2297750}, {"id": "0001209191-22-038729", "src": "INSIDERS", "ticker": "GRPH", "cik": "1815776", "company": "LENZ Therapeutics, Inc.", "company_raw": "Graphite Bio, Inc.", "who": "Abraham Bassan", "who_key": "Bassan Abraham", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on GRPH \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1815776/000120919122038729/0001209191-22-038729-index.htm", "trade_date": "2022-06-21", "timestamp": "2022-06-21", "mins": 2297750}, {"id": "0001209191-22-038730", "src": "INSIDERS", "ticker": "GRPH", "cik": "1815776", "company": "LENZ Therapeutics, Inc.", "company_raw": "Graphite Bio, Inc.", "who": "Rizzuto Carlo", "who_key": "Carlo Rizzuto", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on GRPH \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1815776/000120919122038730/0001209191-22-038730-index.htm", "trade_date": "2022-06-21", "timestamp": "2022-06-21", "mins": 2297750}, {"id": "0001209191-22-038732", "src": "INSIDERS", "ticker": "GRPH", "cik": "1815776", "company": "LENZ Therapeutics, Inc.", "company_raw": "Graphite Bio, Inc.", "who": "Davis Jerel", "who_key": "Jerel Davis", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on GRPH \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1815776/000120919122038732/0001209191-22-038732-index.htm", "trade_date": "2022-06-21", "timestamp": "2022-06-21", "mins": 2297750}, {"id": "0001209191-22-038733", "src": "INSIDERS", "ticker": "GRPH", "cik": "1815776", "company": "LENZ Therapeutics, Inc.", "company_raw": "Graphite Bio, Inc.", "who": "Joseph Jimenez", "who_key": "JIMENEZ JOSEPH", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on GRPH \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1815776/000120919122038733/0001209191-22-038733-index.htm", "trade_date": "2022-06-21", "timestamp": "2022-06-21", "mins": 2297750}, {"id": "0001209191-22-038734", "src": "INSIDERS", "ticker": "GRPH", "cik": "1815776", "company": "LENZ Therapeutics, Inc.", "company_raw": "Graphite Bio, Inc.", "who": "Perry A. Karsen", "who_key": "KARSEN PERRY A", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on GRPH \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1815776/000120919122038734/0001209191-22-038734-index.htm", "trade_date": "2022-06-21", "timestamp": "2022-06-21", "mins": 2297750}, {"id": "0001209191-22-038735", "src": "INSIDERS", "ticker": "GRPH", "cik": "1815776", "company": "LENZ Therapeutics, Inc.", "company_raw": "Graphite Bio, Inc.", "who": "Matthew Porteus", "who_key": "Porteus Matthew", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on GRPH \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1815776/000120919122038735/0001209191-22-038735-index.htm", "trade_date": "2022-06-21", "timestamp": "2022-06-21", "mins": 2297750}, {"id": "0001209191-22-038736", "src": "INSIDERS", "ticker": "GRPH", "cik": "1815776", "company": "LENZ Therapeutics, Inc.", "company_raw": "Graphite Bio, Inc.", "who": "Joanne L. Viney", "who_key": "Viney Joanne L.", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on GRPH \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1815776/000120919122038736/0001209191-22-038736-index.htm", "trade_date": "2022-06-21", "timestamp": "2022-06-21", "mins": 2297750}, {"id": "0001209191-22-024364", "src": "INSIDERS", "ticker": "GRPH", "cik": "1815776", "company": "LENZ Therapeutics, Inc.", "company_raw": "Graphite Bio, Inc.", "who": "Samsara BioCapital, L.P.", "who_key": "Samsara BioCapital, L.P.", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "BUY", "amount": 1731068.48, "score": 52.0, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "The whale tops up: $1.7M of GRPH", "source_url": "https://www.sec.gov/Archives/edgar/data/1815776/000120919122024364/0001209191-22-024364-index.htm", "trade_date": "2022-04-12", "timestamp": "2022-04-12", "mins": 2398550}, {"id": "0001209191-22-024362", "src": "INSIDERS", "ticker": "GRPH", "cik": "1815776", "company": "LENZ Therapeutics, Inc.", "company_raw": "Graphite Bio, Inc.", "who": "Phil Gutry", "who_key": "Gutry Phil", "role": "CHIEF BUSINESS OFFICER", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "BUY", "amount": 20050.0, "score": 34.9, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "GRPH draws $20K from the C-suite", "source_url": "https://www.sec.gov/Archives/edgar/data/1815776/000120919122024362/0001209191-22-024362-index.htm", "trade_date": "2022-04-11", "timestamp": "2022-04-11", "mins": 2399990}, {"id": "0001209191-22-023268", "src": "INSIDERS", "ticker": "GRPH", "cik": "1815776", "company": "LENZ Therapeutics, Inc.", "company_raw": "Graphite Bio, Inc.", "who": "Alethia Young", "who_key": "Young Alethia", "role": "Chief Financial Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "CFO files routine paperwork on GRPH \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1815776/000120919122023268/0001209191-22-023268-index.htm", "trade_date": "2022-04-01", "timestamp": "2022-04-01", "mins": 2414390}, {"id": "0001209191-22-011465", "src": "INSIDERS", "ticker": "GRPH", "cik": "1815776", "company": "LENZ Therapeutics, Inc.", "company_raw": "Graphite Bio, Inc.", "who": "Phil Gutry", "who_key": "Gutry Phil", "role": "CHIEF BUSINESS OFFICER", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "C-suite exec files routine paperwork on GRPH \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1815776/000120919122011465/0001209191-22-011465-index.htm", "trade_date": "2022-02-16", "timestamp": "2022-02-16", "mins": 2477750}, {"id": "0001209191-22-011470", "src": "INSIDERS", "ticker": "GRPH", "cik": "1815776", "company": "LENZ Therapeutics, Inc.", "company_raw": "Graphite Bio, Inc.", "who": "Joshua Lehrer-Graiwer", "who_key": "Lehrer-Graiwer Joshua", "role": "PRESIDENT AND CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "CEO files routine paperwork on GRPH \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1815776/000120919122011470/0001209191-22-011470-index.htm", "trade_date": "2022-02-16", "timestamp": "2022-02-16", "mins": 2477750}, {"id": "0001209191-22-004735", "src": "INSIDERS", "ticker": "GRPH", "cik": "1815776", "company": "LENZ Therapeutics, Inc.", "company_raw": "Graphite Bio, Inc.", "who": "Samsara BioCapital, L.P.", "who_key": "Samsara BioCapital, L.P.", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "BUY", "amount": 1099100.0, "score": 49.2, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "3 insiders pile into GRPH", "source_url": "https://www.sec.gov/Archives/edgar/data/1815776/000120919122004735/0001209191-22-004735-index.htm", "trade_date": "2022-01-24", "timestamp": "2022-01-24", "mins": 2510870}, {"id": "0001209191-22-004346", "src": "INSIDERS", "ticker": "GRPH", "cik": "1815776", "company": "LENZ Therapeutics, Inc.", "company_raw": "Graphite Bio, Inc.", "who": "Samsara BioCapital, L.P.", "who_key": "Samsara BioCapital, L.P.", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "BUY", "amount": 888677.2, "score": 48.0, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Insider cluster: 3 buying GRPH", "source_url": "https://www.sec.gov/Archives/edgar/data/1815776/000120919122004346/0001209191-22-004346-index.htm", "trade_date": "2022-01-20", "timestamp": "2022-01-20", "mins": 2516630}, {"id": "0001209191-21-070500", "src": "INSIDERS", "ticker": "GRPH", "cik": "1815776", "company": "LENZ Therapeutics, Inc.", "company_raw": "Graphite Bio, Inc.", "who": "Samsara BioCapital, L.P.", "who_key": "Samsara BioCapital, L.P.", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "BUY", "amount": 227532.50999999998, "score": 40.9, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Insider cluster: 3 buying GRPH", "source_url": "https://www.sec.gov/Archives/edgar/data/1815776/000120919121070500/0001209191-21-070500-index.htm", "trade_date": "2021-12-15", "timestamp": "2021-12-15", "mins": 2568470}, {"id": "0001209191-21-066742", "src": "INSIDERS", "ticker": "GRPH", "cik": "1815776", "company": "LENZ Therapeutics, Inc.", "company_raw": "Graphite Bio, Inc.", "who": "Samsara BioCapital, L.P.", "who_key": "Samsara BioCapital, L.P.", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "BUY", "amount": 2047102.75, "score": 52.6, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Insider cluster: 3 buying GRPH", "source_url": "https://www.sec.gov/Archives/edgar/data/1815776/000120919121066742/0001209191-21-066742-index.htm", "trade_date": "2021-11-22", "timestamp": "2021-11-22", "mins": 2601590}], "recent_buys": [{"id": "0001209191-22-024364", "src": "INSIDERS", "ticker": "GRPH", "cik": "1815776", "company": "LENZ Therapeutics, Inc.", "company_raw": "Graphite Bio, Inc.", "who": "Samsara BioCapital, L.P.", "who_key": "Samsara BioCapital, L.P.", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "BUY", "amount": 1731068.48, "score": 52.0, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "The whale tops up: $1.7M of GRPH", "source_url": "https://www.sec.gov/Archives/edgar/data/1815776/000120919122024364/0001209191-22-024364-index.htm", "trade_date": "2022-04-12", "timestamp": "2022-04-12", "mins": 2398550}, {"id": "0001209191-22-024362", "src": "INSIDERS", "ticker": "GRPH", "cik": "1815776", "company": "LENZ Therapeutics, Inc.", "company_raw": "Graphite Bio, Inc.", "who": "Phil Gutry", "who_key": "Gutry Phil", "role": "CHIEF BUSINESS OFFICER", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "BUY", "amount": 20050.0, "score": 34.9, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "GRPH draws $20K from the C-suite", "source_url": "https://www.sec.gov/Archives/edgar/data/1815776/000120919122024362/0001209191-22-024362-index.htm", "trade_date": "2022-04-11", "timestamp": "2022-04-11", "mins": 2399990}, {"id": "0001209191-22-004735", "src": "INSIDERS", "ticker": "GRPH", "cik": "1815776", "company": "LENZ Therapeutics, Inc.", "company_raw": "Graphite Bio, Inc.", "who": "Samsara BioCapital, L.P.", "who_key": "Samsara BioCapital, L.P.", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "BUY", "amount": 1099100.0, "score": 49.2, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "3 insiders pile into GRPH", "source_url": "https://www.sec.gov/Archives/edgar/data/1815776/000120919122004735/0001209191-22-004735-index.htm", "trade_date": "2022-01-24", "timestamp": "2022-01-24", "mins": 2510870}, {"id": "0001209191-22-004346", "src": "INSIDERS", "ticker": "GRPH", "cik": "1815776", "company": "LENZ Therapeutics, Inc.", "company_raw": "Graphite Bio, Inc.", "who": "Samsara BioCapital, L.P.", "who_key": "Samsara BioCapital, L.P.", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "BUY", "amount": 888677.2, "score": 48.0, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Insider cluster: 3 buying GRPH", "source_url": "https://www.sec.gov/Archives/edgar/data/1815776/000120919122004346/0001209191-22-004346-index.htm", "trade_date": "2022-01-20", "timestamp": "2022-01-20", "mins": 2516630}, {"id": "0001209191-21-070500", "src": "INSIDERS", "ticker": "GRPH", "cik": "1815776", "company": "LENZ Therapeutics, Inc.", "company_raw": "Graphite Bio, Inc.", "who": "Samsara BioCapital, L.P.", "who_key": "Samsara BioCapital, L.P.", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "BUY", "amount": 227532.50999999998, "score": 40.9, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Insider cluster: 3 buying GRPH", "source_url": "https://www.sec.gov/Archives/edgar/data/1815776/000120919121070500/0001209191-21-070500-index.htm", "trade_date": "2021-12-15", "timestamp": "2021-12-15", "mins": 2568470}, {"id": "0001209191-21-066742", "src": "INSIDERS", "ticker": "GRPH", "cik": "1815776", "company": "LENZ Therapeutics, Inc.", "company_raw": "Graphite Bio, Inc.", "who": "Samsara BioCapital, L.P.", "who_key": "Samsara BioCapital, L.P.", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "BUY", "amount": 2047102.75, "score": 52.6, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Insider cluster: 3 buying GRPH", "source_url": "https://www.sec.gov/Archives/edgar/data/1815776/000120919121066742/0001209191-21-066742-index.htm", "trade_date": "2021-11-22", "timestamp": "2021-11-22", "mins": 2601590}, {"id": "0001209191-21-060627", "src": "INSIDERS", "ticker": "GRPH", "cik": "1815776", "company": "LENZ Therapeutics, Inc.", "company_raw": "Graphite Bio, Inc.", "who": "Samsara BioCapital, L.P.", "who_key": "Samsara BioCapital, L.P.", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "BUY", "amount": 667665.0, "score": 46.5, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Insider cluster: 3 buying GRPH", "source_url": "https://www.sec.gov/Archives/edgar/data/1815776/000120919121060627/0001209191-21-060627-index.htm", "trade_date": "2021-10-15", "timestamp": "2021-10-15", "mins": 2656310}, {"id": "0001209191-21-060060", "src": "INSIDERS", "ticker": "GRPH", "cik": "1815776", "company": "LENZ Therapeutics, Inc.", "company_raw": "Graphite Bio, Inc.", "who": "Samsara BioCapital, L.P.", "who_key": "Samsara BioCapital, L.P.", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "BUY", "amount": 1968972.9899999998, "score": 52.2, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "The whole bench is buying GRPH \u2014 3 and counting", "source_url": "https://www.sec.gov/Archives/edgar/data/1815776/000120919121060060/0001209191-21-060060-index.htm", "trade_date": "2021-10-08", "timestamp": "2021-10-08", "mins": 2666390}, {"id": "0000899243-21-027018", "src": "INSIDERS", "ticker": "GRPH", "cik": "1815776", "company": "LENZ Therapeutics, Inc.", "company_raw": "Graphite Bio, Inc.", "who": "Versant Venture Capital VI, L.P.", "who_key": "Versant Venture Capital VI, L.P.", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "BUY", "amount": 3060000.0, "score": 56.1, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "The whole bench is buying GRPH \u2014 3 and counting", "source_url": "https://www.sec.gov/Archives/edgar/data/1815776/000089924321027018/0000899243-21-027018-index.htm", "trade_date": "2021-06-29", "timestamp": "2021-06-29", "mins": 2811830}, {"id": "0000899243-21-027017", "src": "INSIDERS", "ticker": "GRPH", "cik": "1815776", "company": "LENZ Therapeutics, Inc.", "company_raw": "Graphite Bio, Inc.", "who": "Davis Jerel", "who_key": "Jerel Davis", "role": "Director, 10% Owner", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 3060000.0, "score": 58.6, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "GRPH draws its 4th insider buyer", "source_url": "https://www.sec.gov/Archives/edgar/data/1815776/000089924321027017/0000899243-21-027017-index.htm", "trade_date": "2021-06-29", "timestamp": "2021-06-29", "mins": 2811830}, {"id": "0000899243-21-027014", "src": "INSIDERS", "ticker": "GRPH", "cik": "1815776", "company": "LENZ Therapeutics, Inc.", "company_raw": "Graphite Bio, Inc.", "who": "Smital Shah", "who_key": "Shah Smital", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 99994.0, "score": 39.1, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "5 insiders now buying GRPH", "source_url": "https://www.sec.gov/Archives/edgar/data/1815776/000089924321027014/0000899243-21-027014-index.htm", "trade_date": "2021-06-29", "timestamp": "2021-06-29", "mins": 2811830}, {"id": "0001209191-21-044507", "src": "INSIDERS", "ticker": "GRPH", "cik": "1815776", "company": "LENZ Therapeutics, Inc.", "company_raw": "Graphite Bio, Inc.", "who": "Samsara BioCapital, L.P.", "who_key": "Samsara BioCapital, L.P.", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "BUY", "amount": 8500000.0, "score": 69.5, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "6 insiders pile into GRPH", "source_url": "https://www.sec.gov/Archives/edgar/data/1815776/000120919121044507/0001209191-21-044507-index.htm", "trade_date": "2021-06-29", "timestamp": "2021-06-29", "mins": 2811830}], "institutional": [], "holdings": [], "directors": [], "status": {"status": "delisted", "exchange": null, "note": "No longer in the live ASX listing \u2014 delisted, acquired or merged. Historical filings are retained here; live price history ends at delisting."}, "corporate_actions": {"status_label": "", "items": []}, "key_people": [{"who": "Samsara BioCapital, L.P.", "who_key": "Samsara BioCapital, L.P.", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "bought": 17130118.93, "sold": 0, "net": 17130118.93, "trades": 8, "top_score": 69.5, "lean": "buying", "history": [{"action": "BUY", "amount": 1731068.48, "date": "2022-04-12", "score": 52.0, "source_url": "https://www.sec.gov/Archives/edgar/data/1815776/000120919122024364/0001209191-22-024364-index.htm"}, {"action": "BUY", "amount": 1099100.0, "date": "2022-01-24", "score": 49.2, "source_url": "https://www.sec.gov/Archives/edgar/data/1815776/000120919122004735/0001209191-22-004735-index.htm"}, {"action": "BUY", "amount": 888677.2, "date": "2022-01-20", "score": 48.0, "source_url": "https://www.sec.gov/Archives/edgar/data/1815776/000120919122004346/0001209191-22-004346-index.htm"}, {"action": "BUY", "amount": 227532.50999999998, "date": "2021-12-15", "score": 40.9, "source_url": "https://www.sec.gov/Archives/edgar/data/1815776/000120919121070500/0001209191-21-070500-index.htm"}, {"action": "BUY", "amount": 2047102.75, "date": "2021-11-22", "score": 52.6, "source_url": "https://www.sec.gov/Archives/edgar/data/1815776/000120919121066742/0001209191-21-066742-index.htm"}, {"action": "BUY", "amount": 667665.0, "date": "2021-10-15", "score": 46.5, "source_url": "https://www.sec.gov/Archives/edgar/data/1815776/000120919121060627/0001209191-21-060627-index.htm"}, {"action": "BUY", "amount": 1968972.9899999998, "date": "2021-10-08", "score": 52.2, "source_url": "https://www.sec.gov/Archives/edgar/data/1815776/000120919121060060/0001209191-21-060060-index.htm"}, {"action": "BUY", "amount": 8500000.0, "date": "2021-06-29", "score": 69.5, "source_url": "https://www.sec.gov/Archives/edgar/data/1815776/000120919121044507/0001209191-21-044507-index.htm"}], "latest": {"action": "BUY", "amount": 1731068.48, "date": "2022-04-12", "score": 52.0, "source_url": "https://www.sec.gov/Archives/edgar/data/1815776/000120919122024364/0001209191-22-024364-index.htm"}}, {"who": "Versant Venture Capital VI, L.P.", "who_key": "Versant Venture Capital VI, L.P.", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "bought": 3060000.0, "sold": 0, "net": 3060000.0, "trades": 1, "top_score": 56.1, "lean": "buying", "history": [{"action": "BUY", "amount": 3060000.0, "date": "2021-06-29", "score": 56.1, "source_url": "https://www.sec.gov/Archives/edgar/data/1815776/000089924321027018/0000899243-21-027018-index.htm"}], "latest": {"action": "BUY", "amount": 3060000.0, "date": "2021-06-29", "score": 56.1, "source_url": "https://www.sec.gov/Archives/edgar/data/1815776/000089924321027018/0000899243-21-027018-index.htm"}}, {"who": "Davis Jerel", "who_key": "Jerel Davis", "role": "Director, 10% Owner", "person_type": "BOARD", "person_label": "Board", "bought": 3060000.0, "sold": 0, "net": 3060000.0, "trades": 1, "top_score": 58.6, "lean": "buying", "history": [{"action": "BUY", "amount": 3060000.0, "date": "2021-06-29", "score": 58.6, "source_url": "https://www.sec.gov/Archives/edgar/data/1815776/000089924321027017/0000899243-21-027017-index.htm"}], "latest": {"action": "BUY", "amount": 3060000.0, "date": "2021-06-29", "score": 58.6, "source_url": "https://www.sec.gov/Archives/edgar/data/1815776/000089924321027017/0000899243-21-027017-index.htm"}}, {"who": "Smital Shah", "who_key": "Shah Smital", "role": "Director", "person_type": "BOARD", "person_label": "Board", "bought": 99994.0, "sold": 0, "net": 99994.0, "trades": 1, "top_score": 39.1, "lean": "buying", "history": [{"action": "BUY", "amount": 99994.0, "date": "2021-06-29", "score": 39.1, "source_url": "https://www.sec.gov/Archives/edgar/data/1815776/000089924321027014/0000899243-21-027014-index.htm"}], "latest": {"action": "BUY", "amount": 99994.0, "date": "2021-06-29", "score": 39.1, "source_url": "https://www.sec.gov/Archives/edgar/data/1815776/000089924321027014/0000899243-21-027014-index.htm"}}, {"who": "Phil Gutry", "who_key": "Gutry Phil", "role": "CHIEF BUSINESS OFFICER", "person_type": "C_SUITE", "person_label": "C-Suite", "bought": 20050.0, "sold": 0, "net": 20050.0, "trades": 1, "top_score": 34.9, "lean": "buying", "history": [{"action": "BUY", "amount": 20050.0, "date": "2022-04-11", "score": 34.9, "source_url": "https://www.sec.gov/Archives/edgar/data/1815776/000120919122024362/0001209191-22-024362-index.htm"}], "latest": {"action": "BUY", "amount": 20050.0, "date": "2022-04-11", "score": 34.9, "source_url": "https://www.sec.gov/Archives/edgar/data/1815776/000120919122024362/0001209191-22-024362-index.htm"}}], "activity": [], "announcements": [{"form": "8-K", "date": "2026-07-02", "title": "Material event", "accession": "0001815776-26-000046", "price_sensitive": true}, {"form": "SCHEDULE 13G", "date": "2026-06-26", "title": "Form SCHEDULE 13G", "accession": "0001104659-26-078313", "price_sensitive": false}, {"form": "4", "date": "2026-06-15", "title": "Insider transaction", "accession": "0001231919-26-000640", "price_sensitive": false}, {"form": "4", "date": "2026-06-15", "title": "FORM 4", "accession": "0001796789-26-000004", "price_sensitive": false}, {"form": "4", "date": "2026-06-15", "title": "FORM 4", "accession": "0001340881-26-000001", "price_sensitive": false}, {"form": "4", "date": "2026-06-15", "title": "FORM 4", "accession": "0001200889-26-000001", "price_sensitive": false}, {"form": "4", "date": "2026-06-15", "title": "FORM 4", "accession": "0001297491-26-000001", "price_sensitive": false}, {"form": "4", "date": "2026-06-15", "title": "FORM 4", "accession": "0001825009-26-000001", "price_sensitive": false}, {"form": "4", "date": "2026-06-15", "title": "FORM 4", "accession": "0001816523-26-000005", "price_sensitive": false}, {"form": "8-K", "date": "2026-06-12", "title": "Material event", "accession": "0001815776-26-000041", "price_sensitive": true}, {"form": "10-Q", "date": "2026-05-11", "title": "Quarterly report", "accession": "0001815776-26-000037", "price_sensitive": true}, {"form": "8-K", "date": "2026-05-11", "title": "Material event", "accession": "0001815776-26-000035", "price_sensitive": true}, {"form": "ARS", "date": "2026-04-28", "title": "Form ARS", "accession": "0001815776-26-000029", "price_sensitive": false}, {"form": "DEFA14A", "date": "2026-04-28", "title": "Form DEFA14A", "accession": "0001815776-26-000028", "price_sensitive": false}, {"form": "DEF 14A", "date": "2026-04-28", "title": "Proxy statement", "accession": "0001815776-26-000026", "price_sensitive": false}, {"form": "SCHEDULE 13G", "date": "2026-04-27", "title": "Form SCHEDULE 13G", "accession": "0002012383-26-001701", "price_sensitive": false}, {"form": "SCHEDULE 13G", "date": "2026-04-08", "title": "Form SCHEDULE 13G", "accession": "0001642575-26-000004", "price_sensitive": false}, {"form": "4", "date": "2026-03-30", "title": "FORM 4", "accession": "0001796789-26-000003", "price_sensitive": false}, {"form": "4", "date": "2026-03-30", "title": "FORM 4", "accession": "0001713795-26-000004", "price_sensitive": false}, {"form": "4", "date": "2026-03-30", "title": "FORM 4", "accession": "0001706176-26-000004", "price_sensitive": false}, {"form": "S-8", "date": "2026-03-24", "title": "Employee share plan", "accession": "0001815776-26-000013", "price_sensitive": false}, {"form": "10-K", "date": "2026-03-24", "title": "Annual report", "accession": "0001815776-26-000011", "price_sensitive": true}, {"form": "8-K", "date": "2026-03-24", "title": "Material event", "accession": "0001815776-26-000008", "price_sensitive": true}, {"form": "SCHEDULE 13G/A", "date": "2026-02-17", "title": "Form SCHEDULE 13G/A", "accession": "0001104659-26-016363", "price_sensitive": false}, {"form": "SCHEDULE 13G/A", "date": "2026-02-05", "title": "Form SCHEDULE 13G/A", "accession": "0000315066-26-000453", "price_sensitive": false}], "performance": {"ticker": "GRPH", "has_prices": false, "summary": null, "buys": [{"who": "Samsara BioCapital, L.P.", "person_type": "TEN_PCT", "person_label": "10% Owners", "role": "10% Owner", "amount": 1731068.48, "date": "2022-04-12", "score": 52.0, "ref_price": null, "return": null}, {"who": "Gutry Phil", "person_type": "C_SUITE", "person_label": "C-Suite", "role": "CHIEF BUSINESS OFFICER", "amount": 20050.0, "date": "2022-04-11", "score": 34.9, "ref_price": null, "return": null}, {"who": "Samsara BioCapital, L.P.", "person_type": "TEN_PCT", "person_label": "10% Owners", "role": "10% Owner", "amount": 1099100.0, "date": "2022-01-24", "score": 49.2, "ref_price": null, "return": null}, {"who": "Samsara BioCapital, L.P.", "person_type": "TEN_PCT", "person_label": "10% Owners", "role": "10% Owner", "amount": 888677.2, "date": "2022-01-20", "score": 48.0, "ref_price": null, "return": null}, {"who": "Samsara BioCapital, L.P.", "person_type": "TEN_PCT", "person_label": "10% Owners", "role": "10% Owner", "amount": 227532.50999999998, "date": "2021-12-15", "score": 40.9, "ref_price": null, "return": null}, {"who": "Samsara BioCapital, L.P.", "person_type": "TEN_PCT", "person_label": "10% Owners", "role": "10% Owner", "amount": 2047102.75, "date": "2021-11-22", "score": 52.6, "ref_price": null, "return": null}, {"who": "Samsara BioCapital, L.P.", "person_type": "TEN_PCT", "person_label": "10% Owners", "role": "10% Owner", "amount": 667665.0, "date": "2021-10-15", "score": 46.5, "ref_price": null, "return": null}, {"who": "Samsara BioCapital, L.P.", "person_type": "TEN_PCT", "person_label": "10% Owners", "role": "10% Owner", "amount": 1968972.9899999998, "date": "2021-10-08", "score": 52.2, "ref_price": null, "return": null}, {"who": "Versant Venture Capital VI, L.P.", "person_type": "TEN_PCT", "person_label": "10% Owners", "role": "10% Owner", "amount": 3060000.0, "date": "2021-06-29", "score": 56.1, "ref_price": null, "return": null}, {"who": "Jerel Davis", "person_type": "BOARD", "person_label": "Board", "role": "Director, 10% Owner", "amount": 3060000.0, "date": "2021-06-29", "score": 58.6, "ref_price": null, "return": null}, {"who": "Shah Smital", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 99994.0, "date": "2021-06-29", "score": 39.1, "ref_price": null, "return": null}, {"who": "Samsara BioCapital, L.P.", "person_type": "TEN_PCT", "person_label": "10% Owners", "role": "10% Owner", "amount": 8500000.0, "date": "2021-06-29", "score": 69.5, "ref_price": null, "return": null}]}, "price_series": [], "refreshing": true}